英文名稱 |
中文名稱 |
CAS號 |
操作 |
2-D08 |
化合物2-D08 |
144707-18-6 |
詳細(xì)
|
GSK2982772 |
GSK2982772 |
1622848-92-3 |
詳細(xì)
|
Pitavastatin Calcium |
匹伐他汀鈣 |
147526-32-7 |
詳細(xì)
|
MI 2 |
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 |
1047953-91-2 |
詳細(xì)
|
Ruboxistaurin hydrochloride |
魯伯斯塔鹽酸鹽 |
169939-93-9 |
詳細(xì)
|
Vorapaxar |
沃拉帕沙 |
618385-01-6 |
詳細(xì)
|
Nelfinavir Mesylate |
甲磺酸奈非那韋 |
159989-65-8 |
詳細(xì)
|
Compound 3i (666-15) |
1433286-70-4 |
1433286-70-4 |
詳細(xì)
|
GSK650394 |
2-環(huán)戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 |
890842-28-1 |
詳細(xì)
|
LXH254 |
LXH254 |
1800398-38-2 |
詳細(xì)
|
IBMX |
3-異丁基-1-甲基黃嘌呤 |
28822-58-4 |
詳細(xì)
|
TTNPB |
TTNPB (Arotinoid Acid) |
71441-28-6 |
詳細(xì)
|
OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]環(huán)己烷羧酸 |
936890-98-1 |
詳細(xì)
|
E6446 dihydrochloride |
CS-2089 |
1345675-25-3 |
詳細(xì)
|
KYA1797K |
CS-2581 |
1956356-56-1 |
詳細(xì)
|
Lonidamine |
氯尼達(dá)明 |
50264-69-2 |
詳細(xì)
|
IMD-0354 |
N-[3,5-雙(三氟甲基)苯基]-5-氯-2-羥基苯甲酰胺 |
978-62-1 |
詳細(xì)
|
Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)- |
硝唑尼特 |
55981-09-4 |
詳細(xì)
|
Apigenin |
芹菜素 |
520-36-5 |
詳細(xì)
|
4-(5,6-Dimethoxybenzo[b]thiophen-2-yl)-4-oxobutanoic acid |
MSA-2 |
129425-81-6 |
詳細(xì)
|
Benzenesulfonamide, N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]- |
N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羥基-1-(三氟甲基)乙基]苯基]苯磺酰胺 |
293754-55-9 |
詳細(xì)
|
OSU-03012 (AR-12) |
2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺 |
742112-33-0 |
詳細(xì)
|
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt(1:1), (2S,5R,6R)- |
氨芐西林鈉 |
69-52-3 |
詳細(xì)
|
STF 083010 |
STF 083010 |
307543-71-1 |
詳細(xì)
|
FPS-ZM1 |
N-BENZYL-4-CHLORO-N-CYCLOHEXYLBENZAMIDE |
945714-67-0 |
詳細(xì)
|
ML-141 |
ML 141 |
71203-35-5 |
詳細(xì)
|
TLR2-IN-C29 |
TLR2-IN-C29 |
363600-92-4 |
詳細(xì)
|
Asciminib |
ABL-001 |
1492952-76-7 |
詳細(xì)
|
CCT245737 |
CCT245737 |
1489389-18-5 |
詳細(xì)
|
SIRTINOL |
2-[[(2-羥基-1-萘基)亞甲基]氨基]-N-(1-苯基乙基)苯甲酰胺 |
410536-97-9 |
詳細(xì)
|
Ispinesib |
伊斯平斯 |
336113-53-2 |
詳細(xì)
|
Nirogacestat |
PF-3084014 |
1290543-63-3 |
詳細(xì)
|
Marimastat |
馬立馬司他 |
154039-60-8 |
詳細(xì)
|
AT9283 |
AT9283 |
896466-04-9 |
詳細(xì)
|
Monensin sodium salt |
莫能菌素鈉鹽 |
22373-78-0 |
詳細(xì)
|
MI-503 |
MI-503 |
1857417-13-0 |
詳細(xì)
|
EX229 |
EX229 |
1219739-36-2 |
詳細(xì)
|
BMS-754807 |
BMS-754807 |
1001350-96-4 |
詳細(xì)
|
PHA-665752 |
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氫-2-氧代-3H-吲哚-3-亞基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷 |
477575-56-7 |
詳細(xì)
|
Benzenesulfonyl fluoride, 4-(2-aminoethyl)-, hydrochloride (1:1) |
4-(2-氨乙基)苯磺酰氟鹽酸鹽 |
30827-99-7 |
詳細(xì)
|
AUZ-454 |
K03861 |
853299-07-7 |
詳細(xì)
|
SRT 2104 |
?,斘髁?/td>
| 1093403-33-8 |
詳細(xì)
|
Dubermatinib |
TP-0903 |
1341200-45-0 |
詳細(xì)
|
FR 180204 |
FR180204 |
865362-74-9 |
詳細(xì)
|
Cl-amidine TFA |
Cl-Amidine |
1043444-18-3 |
詳細(xì)
|
PJ34 hydrochloride |
PJ34 |
344458-15-7 |
詳細(xì)
|
Zelavespib (PU-H71) |
6-氨基-8-[(6-碘-1,3-苯并二茂-5-基)硫基]-N-異丙基-9H-嘌呤-9-丙胺 |
873436-91-0 |
詳細(xì)
|
Silibinin |
水飛薊賓 |
22888-70-6 |
詳細(xì)
|
Lys05 |
Lys05 |
1391426-24-6 |
詳細(xì)
|
Unesbulin |
PTC596 |
1610964-64-1 |
詳細(xì)
|
SU 6656 |
SU 6656 |
330161-87-0 |
詳細(xì)
|
GDC-0575 |
(R)-N-(4-(3-氨基哌啶-1-基)-5-溴-1H-吡咯并[2,3-B]吡啶-3-基)環(huán)丙烷甲酰胺 |
1196541-47-5 |
詳細(xì)
|
LJH685 |
2,6-二氟-4-[4-[4-(4-甲基-1-哌嗪基)苯基]-3-吡啶基]苯酚 |
1627710-50-2 |
詳細(xì)
|
CM-272 |
化合物CM-272 |
1846570-31-7 |
詳細(xì)
|
AZ20 |
AZ20 |
1233339-22-4 |
詳細(xì)
|
Cholesterol |
膽固醇 |
57-88-5 |
詳細(xì)
|
Omeprazole |
奧美拉唑 |
73590-58-6 |
詳細(xì)
|
Pracinostat (SB939) |
(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羥基丙烯酰胺 |
929016-96-6 |
詳細(xì)
|
CI-994 |
4-乙酰氨基-N-(2'-氨基苯基)-苯甲酰胺 |
112522-64-2 |
詳細(xì)
|
N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-Morpholin-4-yl-propyl)-pyriMidine-2,4-diaMine |
EHOP-016;N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE |
1380432-32-5 |
詳細(xì)
|
U-104 |
U-104 |
178606-66-1 |
詳細(xì)
|
SR-18292 |
2095432-55-4 |
2095432-55-4 |
詳細(xì)
|
TMP-269 |
TMP269 |
1314890-29-3 |
詳細(xì)
|
PHA-767491 HCl |
1,5,6,7-四氫-2-(4-吡啶基)-4H-吡咯并[3,2-C]吡啶-4-酮鹽酸鹽 |
942425-68-5 |
詳細(xì)
|
LF3 |
LF3 |
664969-54-4 |
詳細(xì)
|
Autophinib |
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE |
1644443-47-9 |
詳細(xì)
|
SR-717 |
SR-717 |
2375421-09-1 |
詳細(xì)
|
SEL120-34A HCl |
1609452-30-3 |
1609452-30-3 |
詳細(xì)
|
ML-323 |
ML323 |
1572414-83-5 |
詳細(xì)
|
Cisapride |
西沙必利 |
81098-60-4 |
詳細(xì)
|
Repotrectinib |
洛普替尼 |
1802220-02-5 |
詳細(xì)
|
6-((4-Chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-2-ol |
MYCI361 |
2289690-31-7 |
詳細(xì)
|
Methyl 3-chloro-5-[(2,4-difluoro-5-phenylphenyl)sulfamoyl]-4-hydroxybenzoate |
NDI-091143 |
2375840-87-0 |
詳細(xì)
|
4-[[(6S,9S,9aS)-1-(benzylcarbamoyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-6-yl]methyl]phenyl] dihydrogen phosphate |
1422253-38-0 |
1422253-38-0 |
詳細(xì)
|
Gedatolisib |
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-嗎啉基)-1,3,5-三嗪-2-基]苯基]脲 |
1197160-78-3 |
詳細(xì)
|
Amiodarone hydrochloride |
胺碘酮鹽酸鹽 |
19774-82-4 |
詳細(xì)
|
Selitrectinib |
LOXO-195 |
2097002-61-2 |
詳細(xì)
|
SC75741 |
SC75741 |
913822-46-5 |
詳細(xì)
|
AZ191 |
DYRK1B抑制劑(AZ191) |
1594092-37-1 |
詳細(xì)
|
NVP-TAE684 |
NVP-TAE684 |
761439-42-3 |
詳細(xì)
|
Hesperadin |
HESPERADIN |
422513-13-1 |
詳細(xì)
|
BP-1-102 |
4-(N-(4-環(huán)己基芐基)-2-((2,3,4,5,6-五氟-N-甲苯基)磺酰氨基)乙酰氨基)-2-羥基苯甲酸 |
1334493-07-0 |
詳細(xì)
|
Savolitinib |
沃利替尼 |
1313725-88-0 |
詳細(xì)
|
PF-04691502 |
2-氨基-8-[反式-4-(2-羥基乙氧基)環(huán)己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1013101-36-4 |
詳細(xì)
|
Pirinixic acid |
匹立尼酸 |
50892-23-4 |
詳細(xì)
|
3BDO |
3BDO, MTOR激酶激活劑, 自噬抑制劑 |
890405-51-3 |
詳細(xì)
|
Epalrestat |
依帕司他 |
82159-09-9 |
詳細(xì)
|
ANA-12 |
ANA-12 |
219766-25-3 |
詳細(xì)
|
STAT5-IN-1 |
STAT5 Inhibitor |
285986-31-4 |
詳細(xì)
|
C178 |
N-(二苯并[B,D]呋喃-3-基)-5-硝基呋喃-2-甲酰胺 |
329198-87-0 |
詳細(xì)
|
IM-12 |
IM-12 |
1129669-05-1 |
詳細(xì)
|
Unii-fys6T7F842 |
阿達(dá)木單抗 |
331731-18-1 |
詳細(xì)
|
CAN508 |
CAY10574 |
140651-18-9 |
詳細(xì)
|
2H-1-Benzopyran-3-acetic acid, 7-amino-4-methyl-2-oxo-, 2,5-dioxo-1-pyrrolidinyl ester |
7-氨基-4-甲基香豆素-3-乙酸 N-琥珀酰亞胺酯 |
113721-87-2 |
詳細(xì)
|
1H-Indole-6-carboxylic acid, 2-[4-[bis(carboxymethyl)amino]-3-[2-[2-[bis(carboxymethyl)amino]-5-methylphenoxy]ethoxy]phenyl]-, potassium salt (1:5) |
熒光鈣探針I(yè)NDO-1FF五鉀鹽 |
132319-56-3 |
詳細(xì)
|
Methanone, (1-methyl-1H-indol-3-yl)[(6R)-4,5,6,7-tetrahydro-1H-benzimidazol-6-yl]- |
拉莫司瓊 |
132036-88-5 |
詳細(xì)
|
5,7-Benzofurandiol, 2,3-dihydro-2-(1E,3E)-1,3-pentadien-1-yl-, (2R)- |
ASPERFURAN |
129277-10-7 |
詳細(xì)
|
LSN 2463359 |
N-異丙基-5-(吡啶-4-基乙炔基)吡啶酰胺 |
1401031-52-4 |
詳細(xì)
|
mebikar |
四氫-1,3,4,6-四甲基咪唑并(4,5-d)咪唑-2,5(1H,3H)-二酮 |
10095-06-4 |
詳細(xì)
|
Methanone, [(3S)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-, methanesulfonate (1:1) |
S(-)-WIN 55 212-3 MESYLATE |
131543-25-4 |
詳細(xì)
|